Results 41 to 50 of about 56,482 (307)
Case Reports in Oncological Medicine, 2021 Background. Clear cell chondrosarcoma (CCCS) is a rare subtype of chondrosarcoma and comprises between 1.6% and 2.5% of all chondrosarcoma. They are known to be chemo- and radiotherapy resistant; surgical resection is therefore the therapy of choice ...
Paulien West +5 more
doaj +1 more source
Imaging of chondrosarcomas [PDF]
Cancer Imaging, 2003 Chondrosarcoma is the commonest primary sarcoma of bone in adults, with a male predominance. Patients are usually between 30 and 70 years old. Clinical symptoms are pain and tenderness with or without a mass, the average duration of symptoms being 1-2 years, but growth may be very slow, especially for pelvic tumours.
L. Ollivier, J. Leclere, Daniel Vanel
openaire +3 more sources
BMC Cancer, 2011 Background Chondrosarcoma is virtually resistant to chemotherapy and radiation therapy. Survivin, the smallest member of the inhibitor of apoptosis protein family, is a critical factor for tumor progression and resistance to conventional therapeutic ...
Grifka Joachim +6 more
doaj +1 more source
International Journal of Surgery Case Reports, 2015 Chondrosarcoma of a rib is a very rare malignant tumor of the bone. Most patients were present with an enlarging painful anterior chest wall tumor. We present a case of an asymptomatic 29-years old female with a tumor size of 10cm×12cm on the left anterior chest wall involving the 8th rib.
Mima Maychet B. Sangma +1 more
openaire +3 more sources
Biomarkers of chondrosarcoma [PDF]
Journal of Clinical Pathology, 2018 Clinical outcome prediction is major concern to patients with cancer. Various molecular markers in various carcinomas have been identified in the past few decades. However, accurate predictors in chondrosarcoma have not been developed, even though chondrosarcoma is the second most common primary bone tumour.
Wonju Jeong, Ha-Jeong Kim
openaire +3 more sources
Dedifferentiated Chondrosarcoma
Definitions, 2020 The term dedifferentiated chondrosarcoma has been applied to tumors in which a well differentiated cartilaginous component, sometimes of demonstrably long duration, is associated with a less differentiated non-cartilaginous component that is assumed to ...
Andy Langdown
semanticscholar +1 more source
Anterior chest wall resection and reconstruction due to recurrent chondrosarcoma: a case report [PDF]
Folia Medica, 2023 Chest wall chondrosarcoma is a rare malignant tumor with aggressive biological behavior. The only available treatment for primary or recurrent chondrosarcoma consists of radical surgical resection because of its well-known chemo- and radioresistance ...
Magdalena Alexieva, Georgi Yankov
doaj +3 more sources
The Korean Journal of Thoracic and Cardiovascular Surgery, 2015 Chondrosarcoma is a rare entity of malignant tumor which arises from cartilaginous tissue, and the literatures on this disease are scarce. The first-line of treatment for cardiac chondrosarcoma is surgery. Due to early local recurrence and distant metastasis, the prognosis is poor even after complete surgical excision.
Sak Lee +5 more
openaire +4 more sources
An improved protocol for small RNA library construction using High Definition adapters [PDF]
, 2015 Next generation sequencing of small RNA (sRNA) libraries is widely used for studying sRNAs in various biological systems. However, cDNA libraries of sRNAs are biased for molecules that are ligated to adapters more or less efficiently than other molecules.
Aravin +28 more
core +1 more source
OncoTargets and Therapy, 2020 Objective Exosomes derived from cancer cells can alter the microenvironment and enhance cancer malignancy through the regulation of peripheral cell functions.
Cheng Cheng +3 more
semanticscholar +1 more source